The below data/statements have not been evaluated by the FDA.

This product is not intended to diagnose, treat, cure, or prevent any disease. The references below only show current research and are not claims, nor intended as such.

Featured Publications

ARAG, an Antioxidant-Rich Gel, Shows Superiority to Mepilex Ag in the Treatment of Deep Partial Thickness Burns without Sacrificing Antimicrobial Efficiency

Brian Michael Cartwright, Sean James Fox, Mary Jane Underdown, William Andrew Clark, and Joseph Andrew Molnar; 2023

Published by: Antioxidants 2023, Volume 12, Issue 6, 1176. https://doi.org/10.3390/antiox12061176

Novel Antimicrobial Topical Gel That Exhibits Inhibitory Effectiveness Toward Common Microbes in Wound Infection (P19-007-19)

W. Andrew Clark, Rachel Ford, Lindsey Vance, Lexis Morley, Thomas Stovall, Leah McHale, Danny Raley, and Sean Fox; 2019

Published by: Current Developments in Nutrition, Volume 3, Issue Supplement 1, June 2019

The Patent

Topical Gel Compositions for the Treatment of Staphylococcal Infections (U.S. Patent 10,912,759)

W. Andrew Clark, Ph.D, RD; February 2019

East Tennessee Health and Sciences Research Studies

A New All-Natural Wound Treatment Gel Shows Strong Inhibitory Activity Against Staphylococcus aureus and Other Wound Pathogens

Tasha Nelson, East Tennessee State University; May 2021

The Inhibitory Effects of an Antimicrobial Gel on the Staphylococcus Species

Mara Trinkle, East Tennessee State University; August 2020

The Inhibitory Effects of a Novel Gel on Staphylococcus Aureus Biofilms

Lindsey Vance, East Tennessee State University; May 2018

Burn Wound Bacteria Susceptibility to a Novel Antimicrobial Compound

Bo H. Marshall, East Tennessee State University; May 2017